Commonwealth Equity Services’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.91M Hold
649,061
﹤0.01% 1798
2026
Q1
$2.4M Sell
649,061
-14,480
-2% -$54.1K ﹤0.01% 1852
2025
Q4
$2.32M Hold
663,541
﹤0.01% 1854
2025
Q3
$1.42M Hold
663,541
﹤0.01% 2300
2025
Q2
$1.49M Buy
663,541
+78,000
+13% +$110K ﹤0.01% 2240
2025
Q1
$802K Buy
585,541
+58,480
+11% +$80.6K ﹤0.01% 2645
2024
Q4
$833K Buy
527,061
+15,500
+3% +$21.7K ﹤0.01% 2536
2024
Q3
$634K Hold
511,561
﹤0.01% 2706
2024
Q2
$685K Buy
511,561
+14,481
+3% +$21.4K ﹤0.01% 2579
2024
Q1
$676K Buy
+497,080
New +$1.06M ﹤0.01% 2557
2018
Q3
Sell
-11,400
Closed -$50K 2791
2018
Q2
$50K Sell
11,400
-1,500
-12% -$5.53K ﹤0.01% 2657
2018
Q1
$38K Buy
12,900
+1,000
+8% +$2.57K ﹤0.01% 2611
2017
Q4
$31K Hold
11,900
﹤0.01% 2592
2017
Q3
$40K Sell
11,900
-1,300
-10% -$3.36K ﹤0.01% 2483
2017
Q2
$33K Buy
+13,200
New +$32.4K ﹤0.01% 2440
2017
Q1
Sell
-10,700
Closed -$38K 2417
2016
Q4
$38K Hold
10,700
﹤0.01% 2253
2016
Q3
$56K Buy
+10,700
New +$34.7K ﹤0.01% 2161

Other funds holding APYX

Commonwealth Equity Services's APYX Position: Q2 2026 in Review

Commonwealth Equity Services held its Apyx Medical (APYX) position steady in Q2 2026 at 649,061 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1798.

Commonwealth Equity Services first reported a position in APYX in Q3 2016 and has held it in 17 quarters since. 9 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Commonwealth Equity Services held 649,061 shares of Apyx Medical worth $2.91M as of Q2 2026.
  • Commonwealth Equity Services left its Apyx Medical share count unchanged in Q2 2026.
  • Apyx Medical made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #1798 holding.
  • Commonwealth Equity Services first reported a position in Apyx Medical in Q3 2016 and has held it in 17 quarters since.
  • 9 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.